SHARON CURTIS: Open Payments
NPI 1679796403 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,776 in 82 payments from 11 companies in 2025. Trend: 2023 $38,142 · 2024 $24,543 · 2025 $35,776
Honoraria: $29,138Travel & lodging: $4,081Food & beverage: $2,550Education: $8
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 53 | $34,477 |
| Teva Pharmaceuticals USA, Inc. | 3 | $297 |
| Corium, LLC | 9 | $210 |
| Tris Pharma Inc | 4 | $195 |
| ABBVIE INC. | 4 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $140 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Collegium Pharmaceutical, Inc. | 1 | $30 |
Products named: Qelbree, UZEDY, Azstarys, VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR, COBENFY.
Industry payments across IN — which companies pay providers there.
